Opinion

Video

MIRASOL trial and DESTINY-PanTumor02 Trial Overview

Ronald D. Alvarez, MD, MBA, gives an analysis of the MIRASOL and DESTINY-PanTumor02 trials, including a comparison of study arms and discussion of HER2/neu targeting.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Dr Sundar Jagannath
1 expert in this video
4 experts in this video
4 experts in this video
Dr Caroline Vovan
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo